Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jefferies Financial
JEF
5
Amazon
AMZN
HK Stock MarketDetailed Quotes
00775 CKLIFE SCIENCES
- 0.930
- +0.090+10.71%
Not Open Apr 28 16:09 CST
8.94BMarket Cap-71.54P/E (TTM)
0.960High0.820Low64.21MVolume0.840Open0.840Pre Close58.63MTurnover0.67%Turnover RatioLossP/E (Static)9.61BShares0.96052wk High2.55P/B8.94BFloat Cap0.32052wk Low--Dividend TTM9.61BShs Float2.172Historical High--Dividend LFY16.67%Amplitude0.072Historical Low0.913Avg Price2000Lot Size--Div YieldTTM--Div Yield LFY
About CKLIFE SCIENCES Company
Changjiang Life Science Group Co., Ltd. is listed on the Hong Kong Stock Exchange Limited. Based on the mission of improving the quality of human life, Changjiang Life Technology is engaged in product R&D, manufacturing, commercialization, promotion, sales and investment. The projects and assets involved cover the three major categories of health care, medicine and diagnosis, and agriculture-related businesses. Changjiang Life Science is a member of Changjiang Hutchison Industrial Group.
Company Profile
Symbol00775
Company NameCKLIFE SCIENCES
ISINKYG2176J1058
Listing DateSep 8, 2008
FoundedAug 10, 2001
Registered AddressCayman Islands
Chairmanzeju li
Secretaryyizhi yang
Audit InstitutionDeloitte Guan Huang Chen Fang Certified Public Accountants
Company CategoryOther
Registered OfficeP.O. Box 309 GT, Ugland House, South Church Street, Grand Cayman, Cayman Islands
Head Office and Principal Place of Business2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong
Fiscal Year Ends12-31
Employees2033
MarketHong Kong motherboard
Phone(852) 2126 1212
Fax(852) 2126 1211
Emailinfo@ck-lifesciences.com
Business Changjiang Life Science Group Co., Ltd. is an investment holding company mainly engaged in the development and sales of health products. The company is mainly engaged in human health business such as R&D, production, promotion and sales of health products and pharmaceutical products. The company's health product brands include Lipa, Vitaquest, and Sante Naturelle. The pharmaceutical products it has developed mainly include cancer-related drugs and pain relievers. The Agribusiness segment operates vineyards and develops, produces, promotes and sells agricultural and related products. Its agricultural products include fertilizer products and plant protection products.
Company Executives
- Name
- Position
- Salary
- zeju li
- Presidencies, Executive Director, Chairman of the Executive Committee, Remuneration Committee Members, Nomination Committee Members
- 125.00K
- qinglin gan
- President, Executive Director, Executive Committee Members
- 3.08M
- dequan ye
- Executive Director, Senior Vice President, Investment Director, Executive Committee Members, Authorized Representative
- 1.10M
- yingcai yu
- Vice-chairman, Executive Director, Executive Committee Members
- 15.26M
- Lance Richard Lee Yuen
- VP, Executive Director, Director of Administration, Executive Committee Members
- 6.88M
- jianming du
- VP, Executive Director, Director of Science, Executive Committee Members
- 6.44M
- Peter Peace Tulloch
- Non-executive Directors
- 75.00K
- liqihua guo
- Independent Non-Executive Director, Remuneration Committee Chairman, Nomination Committee Members
- 100.00K
- qichang guan
- Independent Non-Executive Director, Chairman of the Audit Committee
- 155.00K
- Paul Joseph Tighe
- Independent Non-Executive Director, Chairman of the Nomination Committee, Audit Committee Members
- 205.00K
- bishi luo
- Independent Non-Executive Director, Nomination Committee Members, Audit Committee Members, Remuneration Committee Members
- 205.00K
- jingshi zhao
- Director of Legal Affairs
- --
- fulin xia
- Director of Business Development
- --
- shimin he
- Vice President of Corporate Development, Executive Committee Members
- --
- huiwen he
- Director of Business Development
- --
- tanghuici ban
- Director of Corporate Affairs
- --
- hong wang
- Director of Preclinical Development
- --
- huanlin huang
- Chief Financial Officer, Executive Committee Members
- --
- youlian huang
- Senior Manager of Human Resources and Administration
- --
- botao hu
- Vice President of Global Operations, Executive Committee Members
- --
- huiyan zhen
- Senior Internal Audit Manager
- --
- yizhi yang
- Authorized Representative, Company Secretary
- --
- qiaomei yu
- General Manager of Wei Jiansheng Hong Kong Co., Ltd.
- --
- deyong zhang
- Vice President of Translational Medicine Research
- --
- BARRINGTON-CASE, Angus
- Executive Director of Regenal Investments Pty Limited
- --
- BRUEGGMAN, Patrick
- President and Executive Director of Vitaquest International LLC
- --
- HERRON, Mark
- Executive Director, Australian Agribusiness (Holdings) Pty Ltd
- --
- MALLON, Patrick
- Executive Director of Polynoma LLC (“Polynoma”)
- --
- MCLEISH, Euan
- Dominion Salt Ltd Executive Director
- --
- NEWTON, Peter
- Executive Director of Cheetham Salt Group (“Cheetham”)
- --
- TANNA, Rob
- Executive Director of Lipa Pharmaceuticals Ltd (“Lipa”)
- --
- THOMASSIN, Jean-Philippe
- Santé Naturelle Adrien Gagnon Ltd. President and Executive Director
- --
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs